Change of the inspiratory peak flow after bronchial dilatation on patients with median to severe chronic obstruktiv lung disease

Trial Profile

Change of the inspiratory peak flow after bronchial dilatation on patients with median to severe chronic obstruktiv lung disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2014

At a glance

  • Drugs Formoterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2011 According to ClinicalTrials.Gov record the study is completed and the trial end date is 1 Oct 2007; the EudraCT record states that the trial is still ongoing.
    • 30 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top